Systemic treatment of AIDS-related Kaposi sarcoma: Current status and perspectives

Kaposi’s sarcoma (KS) is the most frequent type of cancer in patients with Acquired Immune Deficiency Syndrome (AIDS). In the western world, its incidence decreased dramatically in the era of highly active anti-retroviral therapy (HAART). In contrast, the incidence of KS has been steadily climbing i...

Full description

Saved in:

Bibliographic Details
Published in:	Cancer treatment reviews Vol. 32; no. 6; pp. 445 - 455
Main Authors:	Vanni, Tazio, Sprinz, Eduardo, Machado, Marcelo Warlet, Santana, Rodrigo de C., Fonseca, Benedito Antonio L., Schwartsmann, Gilberto
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier Ltd 01.10.2006
Subjects:	Acquired Immunodeficiency Syndrome - complications Acquired Immunodeficiency Syndrome - drug therapy Adult AIDS Anthracyclines - administration & dosage Antineoplastic Combined Chemotherapy Protocols Antiretroviral Therapy, Highly Active Antiviral Agents - therapeutic use Clinical Trials as Topic Human immunodeficiency virus Humans Interferons - therapeutic use Kaposi’s Sarcoma Liposomes Male Paclitaxel - administration & dosage Sarcoma, Kaposi - drug therapy Sarcoma, Kaposi - epidemiology Sarcoma, Kaposi - virology Treatment Kaposi’s Sarcoma AIDS Treatment
ISSN:	0305-7372, 1532-1967
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!